STAT+: Gilead wins a key battle with the CDC over patents for its Truvada HIV pill
The judge noted the CDC did not alert Gilead to a patent on Truvada until 2016, one year after it had been issued.
News
STAT+: Roche’s failed Alzheimer’s studies lend weight to an emerging idea about potential treatments
Roche’s failed Alzheimer’s studies lend weight to an emerging idea about potential treatments. […]
News
STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharma industry. […]
News
STAT+: Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug
In a victory for Gilead, Brazilian antitrust authorities dismissed a complaint alleging the company charged “abusive” prices for a hepatitis C treatment. […]
